Comparative Analyses of SUV420H1 Isoforms and SUV420H2 Reveal Differences in Their Cellular Localization and Effects on Myogenic Differentiation

被引:31
|
作者
Tsang, Leanna W. K. [1 ]
Hu, Ninghe [1 ]
Underhill, D. Alan [1 ,2 ]
机构
[1] Univ Alberta, Sch Human Dev, Dept Med Genet, Edmonton, AB, Canada
[2] Univ Alberta, Dept Oncol, Sch Canc Engn & Imaging Sci, Fac Med & Dent, Edmonton, AB, Canada
来源
PLOS ONE | 2010年 / 5卷 / 12期
基金
加拿大健康研究院;
关键词
HISTONE METHYLTRANSFERASE ACTIVITY; H4K20; TRIMETHYLATION; GENE-EXPRESSION; H4-LYSINE; 20; METHYLATION; LYSINE-20; H4; CHROMATIN; MONOMETHYLATION; PR-SET7;
D O I
10.1371/journal.pone.0014447
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Methylation of histone H4 on lysine 20 plays critical roles in chromatin structure and function via mono( H4K20me1), di-(H4K20me2), and trimethyl (H4K20me3) derivatives. In previous analyses of histone methylation dynamics in mid-gestation mouse embryos, we documented marked changes in H4K20 methylation during cell differentiation. These changes were particularly robust during myogenesis, both in vivo and in cell culture, where we observed a transition from H4K20me1 to H4K20me3. To assess the significance of this change, we used a gain-of-function strategy involving the lysine methyltransferases SUV420H1 and SUV420H2, which catalyze H4K20me2 and H4K20me3. At the same time, we characterized a second isoform of SUV420H1 (designated SUV420H1_i2) and compared the activity of all three SUV420H proteins with regard to localization and H4K20 methylation. Principal Findings: Immunofluorescence revealed that exogenous SUV420H1_i2 was distributed throughout the cell, while a substantial portion of SUV420H1_i1 and SUV420H2 displayed the expected association with constitutive heterochromatin. Moreover, SUV420H1_i2 distribution was unaffected by co-expression of heterochromatin protein-1 alpha, which increased the targeting of SUV420H1_i1 and SUV420H2 to regions of pericentromeric heterochromatin. Consistent with their distributions, SUV420H1_i2 caused an increase in H4K20me3 levels throughout the nucleus, whereas SUV420H1_i1 and SUV420H2 facilitated an increase in pericentric H4K20me3. Striking differences continued when the SUV420H proteins were tested in the C2C12 myogenic model system. Specifically, although SUV420H1_i2 induced precocious appearance of the differentiation marker Myogenin in the presence of mitogens, only SUV420H2 maintained a Myogenin-enriched population over the course of differentiation. Paradoxically, SUV420H1_i1 could not be expressed in C2C12 cells, which suggests it is under post-transcriptional or post-translational control. Conclusions: These data indicate that SUV420H proteins differ substantially in their localization and activity. Importantly, SUV420H2 can induce a transition from H4K20me1 to H4K20me3 in regions of constitutive heterochromatin that is sufficient to enhance myogenic differentiation, suggesting it can act an as epigenetic 'switch' in this process.
引用
收藏
页数:12
相关论文
共 33 条
  • [21] Histone methyltransferase SUV420H1/KMT5B contributes to poor prognosis in hepatocellular carcinoma
    Kato, Hirotaka
    Hayami, Shinya
    Ueno, Masaki
    Suzaki, Norihiko
    Nakamura, Masashi
    Yoshimura, Tomohiro
    Miyamoto, Atsushi
    Shigekawa, Yoshinobu
    Okada, Ken-Ichi
    Miyazawa, Motoki
    Kitahata, Yuji
    Ehata, Shogo
    Hamamoto, Ryuji
    Yamaue, Hiroki
    Kawai, Manabu
    CANCER SCIENCE, 2024, 115 (02) : 385 - 400
  • [22] Protocol for preparing SUV420H1 in complex with the nucleosome containing H2A.Z and H4K20Ecx for structure determination
    Huang, Li
    Zhou, Zheng
    STAR PROTOCOLS, 2024, 5 (03):
  • [23] Loss of histone H4 lysine 20 trimethylation in osteosarcoma is associated with aberrant expression ofhistone methyltransferase SUV420H2
    Piao, Lianhua
    Yuan, Xiaofeng
    Wang, Luhui
    Xu, Xiaoshuang
    Zhuang, Ming
    Li, Jinggao
    Kong, Ren
    Liu, Zhiwei
    ONCOLOGY LETTERS, 2020, 20 (04)
  • [24] SUV420H1 depletion reveals therapeutic potential in HPV-negative head and neck squamous cell carcinoma
    Moshiri, Arfa
    Kim, Sohyoung
    Luff, Marie
    Saloura, Vassiliki
    CANCER RESEARCH, 2024, 84 (06)
  • [25] H4K20me3 methyltransferase SUV420H2 shapes the chromatin landscape of pluripotent embryonic stem cells
    Kurup, Jiji T.
    Han, Zhijun
    Jin, Wenfei
    Kidder, Benjamin L.
    DEVELOPMENT, 2020, 147 (23):
  • [26] Hepatic inactivation of the epigenetic regulators Suv420h1-h2 mitigates NAFLD development and progression in mice
    Pagani, Alessia
    Furiosi, Valeria
    Pettinato, Mariateresa
    Volpe, Letizia Bavuso
    Altamura, Sandro
    Nai, Antonella
    Gabellini, Davide
    Pedrotti, Simona
    Silvestri, Laura
    JOURNAL OF HEPATOLOGY, 2023, 78 : S749 - S750
  • [27] Prognostic relevance of SUV420H2 (KMT5C) gene expression in clear cell renal cell carcinoma: Implications for patients of African ancestry
    Reams, Romonia Renee
    Heyliger, Simone
    Saulsbury, Marilyn
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2023, 32 (01) : 261 - 261
  • [28] SUV420H2 suppresses breast cancer cell invasion through down regulation of the SH2 domain-containing focal adhesion protein tensin-3
    Shinchi, Yoshimi
    Hieda, Miki
    Nishioka, Yu
    Matsumoto, Ayaka
    Yokoyama, Yuhki
    Kimura, Hiroshi
    Matsuura, Shuji
    Matsuura, Nariaki
    EXPERIMENTAL CELL RESEARCH, 2015, 334 (01) : 90 - 99
  • [29] Correction: miR-29a contributes to breast cancer cells epithelial–mesenchymal transition, migration, and invasion via downregulating histone H4K20 trimethylation through directly targeting SUV420H2
    You Wu
    Wanyue Shi
    Tingting Tang
    Yidong Wang
    Xin Yin
    Yanlin Chen
    Yanfeng Zhang
    Yun Xing
    Yumeng Shen
    Tiansong Xia
    Changying Guo
    Yi Pan
    Liang Jin
    Cell Death & Disease, 10
  • [30] miR-29a contributes to breast cancer cells epithelial–mesenchymal transition, migration, and invasion via down-regulating histone H4K20 trimethylation through directly targeting SUV420H2
    You Wu
    Wanyue Shi
    Tingting Tang
    Yidong Wang
    Xin Yin
    Yanlin Chen
    Yanfeng Zhang
    Yun Xing
    Yumeng Shen
    Tiansong Xia
    Changying Guo
    Yi Pan
    Liang Jin
    Cell Death & Disease, 10